The Washington Post8d
Americans might finally have to face what’s in their food
The proposed label has been a long time in the making. More than 25 years ago, Congress directed federal agencies, including the FDA and the Centers ... are healthy or not, consumers can look ...
Zoetis announces updated label for Librela
Zoetis (ZTS) announced that it has updated the U.S. label for Librela, following its submission of a supplement to the FDA. This supplement ...
Do food warning labels actually work? Answering your questions.
Readers had a lot to say about my latest column on the Food and Drug Administration’s proposed front-of-package labels. Most ...
MedCity News7d
New FDA Approval Adds Chronic Kidney Disease to Ozempic’s Label
and Novo Nordisk can now claim to have the first medication in this class approved for chronic kidney disease. The FDA has expanded the label of Ozempic, approving the Novo Nordisk product for ...
Nasdaq8d
Supernus Pharmaceuticals Announces FDA Approval for Updated Qelbree Label Including New Pharmacodynamic Data and Lactation Information
The company does not provide detailed information ... announced that the U.S. Food and Drug Administration (FDA) has approved an update for the label for Qelbree (viloxazine extended-release ...
BioSpace4d
FDA Approves Vertex’s Journavx as First New Pain Drug in Decades
The greenlight for Journavx (suzetrigine), which comes on the heels of a $7.4 billion opioid settlement, could spark momentum ...
US FDA approves Novo Nordisk's Ozempic to cut risk of diabetic kidney disease progression
The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as ...
GlobalData on MSN13d
J&J’s Spravato receives FDA label expansion for depression monotherapy
The FDA’s decision marks J&J's Spravato as the first monotherapy for adults with treatment-resistant depression.
Sierra Sun Times1d
FDA Approves Non-Opioid Treatment for Moderate to Severe Acute Pain as Agency Continues to Take Steps to Support New Approaches for Pain Management
FDA Approves Non-Opioid Treatment for Moderate to Severe Acute Pain as Agency Continues to Take Steps to Support New ...